ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,360, issued on March 25, was assigned to The George Washington University (Washington).
"Compositions and methods for treatment of anticancer-drug resistant cancers" was invented by Wenge Zhu (Germantown, Md.), Jing Li (Arlington, Va.) and Yiliang Li (Tianjin, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "Embodiments of the instant disclosure relate to novel methods and compositions for treating tumors resistant to one or more anticancer drugs, such as platinum-based chemotherapeutics."
The patent was filed on Sept. 14, 2022, under Application No. 17/944,506.
*For further information, including images, charts and tables, please visit: http...